Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 0
No TA breakdown available.
R&D Momentum
62/100
Pipeline Velocity
42/100
Trial Completion Rate
100/100
Pipeline Concentration
100/100
Pipeline Freshness
68/100
Activity
Last 14 days
The Effect of Ultrasonic and Diode Laser-Activated Irrigation on Postoperative Pain Reduction Following Conventional Root Canal Treatment: A Randomized Clinical Trial.
Effect of Conventional and Nano-Formulated Metronidazole as an Alternative Irrigant With and Without Activation on Post-operative Pain and Endotoxin Levels in Necrotic Teeth With Apical Periodontitis: A Randomized Clinical Study
Efficacy of Combination of TECAR and Functional Electrical Stimulation on Hand Function in Spastic Upper Limb Stroke Patients: A Randomized Controlled Trial
Prevalence of CYP2C19 Genetic Polymorphisms Among Egyptian Patients Receiving Clopidogrel (Plavix®) Following Percutaneous Coronary Intervention: A Prospective Multicenter Cohort Study
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)